RSV, Respiratory syncytial Virus (Motavizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-RSV, Respiratory syncytial Virus (Motavizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityRSV, Respiratory syncytial Virus (Motavizumab biosimilar)
CloneMotavizumab
Host SpeciesRecombinant
Reactive Speciesn/a
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-RSV Recombinant Antibody (Motavizumab). Motavizumab (proposed INN, trade name Numax) is a humanized monoclonal antibody. It is being investigated by MedImmune (today a subsidiary of AstraZeneca) for the prevention of respiratory syncytial virus infection in high-risk infants. As of September 2009, it is undergoing Phase II and III clinical trials.
Immunogenn/a
Other NamesAnti-RSV Recombinant Antibody, Research Grade Motavizumab, Anti-RSV Recombinant Antibody(Motavizumab), MEDI-524, Antibody Drug Analogues, Monoclonal Antibody, YR1031, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 677010-34-3
Catalog #YR1031
Priceplease inquire
Order / More InfoRSV, Respiratory syncytial Virus (Motavizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.